|
3877
|
BMS-986299
|
First-in-class NLRP3 agonist |
€140.00
|
|
3475
|
Dapansutrile
|
Selective and orally active NLRP3 inflammasome inhibitor |
€70.00
|
|
3839
|
JC2-11
|
Inhibitor of the NLRP3/NLRC4/AIM2 inflammasomes |
€120.00
|
|
4063
|
KIN1148
|
IRF3 agonist; Influenza vaccine adjuvant |
€120.00
|
|
4061
|
KIN1400
|
IRF3 agonist; RLR pathway agonist |
€120.00
|
|
4062
|
KIN1408
|
IRF3 agonist; RLR pathway agonist |
€120.00
|
|
4052
|
MCC950 sodium salt
|
Highly potent and selective NLRP3 inflammasome inhibitor |
€120.00
|
|
1888
|
ML 130
|
Potent and selective inhibitor of NOD1 (NLRC1) |
€95.00
|
|
3215
|
RIG012
|
Potent antagonist of the RIG-I innate immune receptor |
€150.00
|